Calumet, Inc. (NASDAQ:CLMT) Stock Has Average Price Target of $54.75 According to Analysts

Calumet, Inc. (NASDAQ:CLMT – Get Free Report) has been assigned an average recommendation of “Hold” from the seven ratings firms that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $54.00.

CLMT has been the topic of a number of research reports. The Goldman Sachs Group reissued a “neutral” rating and issued a $57.00 price objective on shares of Calumet in a report on Wednesday, October 21st. TD Cowen dropped their price target on shares of Calumet from $40.00 to $37.00 and set a “hold” rating on the stock in a research note on Wednesday. Zacks Research downgraded shares of Calumet from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 3rd. Wall Street Zen upgraded Calumet from a “hold” rating to a “buy” rating in a research note on Saturday, November 14th. Finally, UBS Group raised their target price on Calumet from $26.00 to $47.00 and gave the stock a “neutral” rating in a report on Tuesday, August 25th.

Read Our Latest Stock Analysis on Calumet

Calumet Stock Down 4.7%

Shares of NASDAQ CLMT opened at $30.32 on Monday. Calumet has a twelve month low of $17.85 and a twelve month high of $59.87. The firm has a market cap of $2.67 billion, a P/E ratio of -13.48, a PEG ratio of 0.21 and a beta of 0.65. The company has a 50 day moving average of $50.49 and a 200 day moving average of $39.48.

Calumet (NASDAQ:CLMT – Get Free Report) last issued its earnings results on Friday, November 6th. The oil and gas company reported $2.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.63 by $1.28. Calumet had a negative net margin of 3.73% and a negative return on equity of 32.93%. The company had revenue of $1.68 billion for the quarter, compared to analysts’ expectations of $1.34 billion. During the same quarter last year, the company posted $3.61 earnings per share. The firm’s quarterly revenue was up 56.1% on a year-over-year basis. As a group, equities analysts expect that Calumet will post 3.09 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Zacks Investment Management bought a new position in shares of Calumet during the 3rd quarter valued at approximately $218,000. BlueCrest Capital Management Ltd raised its stake in Calumet by 12.5% during the 3rd quarter. BlueCrest Capital Management Ltd now owns 90,000 shares of the oil and gas company’s stock worth $4,714,000 after acquiring an additional 10,000 shares during the period. Toronto Dominion Bank bought a new stake in Calumet during the 3rd quarter worth approximately $291,000. FORA Capital LLC purchased a new position in Calumet during the third quarter valued at approximately $923,000. Finally, Caxton Associates LLP purchased a new position in Calumet during the third quarter valued at approximately $3,660,000. 34.41% of the stock is owned by hedge funds and other institutional investors.

Calumet Company Profile

(Get Free Report)

Calumet, Inc. is a U.S.-based producer of specialty hydrocarbon products, renewable fuels and conventional fuels. Its products serve customers in industries such as manufacturing, transportation, energy and consumer goods. The company’s specialty products include lubricating oils, solvents, waxes, petrolatums and asphalt. It also produces gasoline, diesel and other fuels, and through its Montana Renewables business makes lower-carbon fuels, including sustainable aviation fuel and renewable diesel.

See Also

Analyst Recommendations for Calumet (NASDAQ:CLMT)

Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.